South Korea Daratumumab Market (2025-2031) | Companies, Competition, Analysis, Restraints, Opportunities, Challenges, Outlook, Segments, Segmentation, Industry, Revenue, Competitive, Forecast, Supply, Drivers, Share, Investment Trends, Size, Value, Consumer Insights, Strategic Insights, Pricing Analysis, Growth, Strategy, Demand, Trends

Market Forecast By Product Type (Injectable Daratumumab, Daratumumab Biosimilar, Combination Therapy, Oral Daratumumab), By Technology Type (Monoclonal Antibody, Biosimilar Technology, Immunotherapy, Oral Drug Delivery), By End User (Oncologists, Healthcare Providers, Cancer Patients, Cancer Treatment Centers), By Application (Multiple Myeloma Treatment, Cancer Therapy, Co-Therapy with Chemotherapy, Advanced Myeloma Care) And Competitive Landscape
Product Code: ETC11704810 Publication Date: Apr 2025 Updated Date: Aug 2025 Product Type: Market Research Report
Publisher: 6Wresearch Author: Bhawna Singh No. of Pages: 65 No. of Figures: 34 No. of Tables: 19

Key Highlights of the Report:

  • South Korea Daratumumab Market Outlook
  • Market Size of South Korea Daratumumab Market, 2024
  • Forecast of South Korea Daratumumab Market, 2031
  • Historical Data and Forecast of South Korea Daratumumab Revenues & Volume for the Period 2021-2031
  • South Korea Daratumumab Market Trend Evolution
  • South Korea Daratumumab Market Drivers and Challenges
  • South Korea Daratumumab Price Trends
  • South Korea Daratumumab Porter's Five Forces
  • South Korea Daratumumab Industry Life Cycle
  • Historical Data and Forecast of South Korea Daratumumab Market Revenues & Volume By Product Type for the Period 2021-2031
  • Historical Data and Forecast of South Korea Daratumumab Market Revenues & Volume By Injectable Daratumumab for the Period 2021-2031
  • Historical Data and Forecast of South Korea Daratumumab Market Revenues & Volume By Daratumumab Biosimilar for the Period 2021-2031
  • Historical Data and Forecast of South Korea Daratumumab Market Revenues & Volume By Combination Therapy for the Period 2021-2031
  • Historical Data and Forecast of South Korea Daratumumab Market Revenues & Volume By Oral Daratumumab for the Period 2021-2031
  • Historical Data and Forecast of South Korea Daratumumab Market Revenues & Volume By Technology Type for the Period 2021-2031
  • Historical Data and Forecast of South Korea Daratumumab Market Revenues & Volume By Monoclonal Antibody for the Period 2021-2031
  • Historical Data and Forecast of South Korea Daratumumab Market Revenues & Volume By Biosimilar Technology for the Period 2021-2031
  • Historical Data and Forecast of South Korea Daratumumab Market Revenues & Volume By Immunotherapy for the Period 2021-2031
  • Historical Data and Forecast of South Korea Daratumumab Market Revenues & Volume By Oral Drug Delivery for the Period 2021-2031
  • Historical Data and Forecast of South Korea Daratumumab Market Revenues & Volume By End User for the Period 2021-2031
  • Historical Data and Forecast of South Korea Daratumumab Market Revenues & Volume By Oncologists for the Period 2021-2031
  • Historical Data and Forecast of South Korea Daratumumab Market Revenues & Volume By Healthcare Providers for the Period 2021-2031
  • Historical Data and Forecast of South Korea Daratumumab Market Revenues & Volume By Cancer Patients for the Period 2021-2031
  • Historical Data and Forecast of South Korea Daratumumab Market Revenues & Volume By Cancer Treatment Centers for the Period 2021-2031
  • Historical Data and Forecast of South Korea Daratumumab Market Revenues & Volume By Application for the Period 2021-2031
  • Historical Data and Forecast of South Korea Daratumumab Market Revenues & Volume By Multiple Myeloma Treatment for the Period 2021-2031
  • Historical Data and Forecast of South Korea Daratumumab Market Revenues & Volume By Cancer Therapy for the Period 2021-2031
  • Historical Data and Forecast of South Korea Daratumumab Market Revenues & Volume By Co-Therapy with Chemotherapy for the Period 2021-2031
  • Historical Data and Forecast of South Korea Daratumumab Market Revenues & Volume By Advanced Myeloma Care for the Period 2021-2031
  • South Korea Daratumumab Import Export Trade Statistics
  • Market Opportunity Assessment By Product Type
  • Market Opportunity Assessment By Technology Type
  • Market Opportunity Assessment By End User
  • Market Opportunity Assessment By Application
  • South Korea Daratumumab Top Companies Market Share
  • South Korea Daratumumab Competitive Benchmarking By Technical and Operational Parameters
  • South Korea Daratumumab Company Profiles
  • South Korea Daratumumab Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the South Korea Daratumumab Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the South Korea Daratumumab Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 South Korea Daratumumab Market Overview

3.1 South Korea Country Macro Economic Indicators

3.2 South Korea Daratumumab Market Revenues & Volume, 2021 & 2031F

3.3 South Korea Daratumumab Market - Industry Life Cycle

3.4 South Korea Daratumumab Market - Porter's Five Forces

3.5 South Korea Daratumumab Market Revenues & Volume Share, By Product Type, 2021 & 2031F

3.6 South Korea Daratumumab Market Revenues & Volume Share, By Technology Type, 2021 & 2031F

3.7 South Korea Daratumumab Market Revenues & Volume Share, By End User, 2021 & 2031F

3.8 South Korea Daratumumab Market Revenues & Volume Share, By Application, 2021 & 2031F

4 South Korea Daratumumab Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of multiple myeloma in South Korea

4.2.2 Growing awareness and adoption of daratumumab as a treatment option

4.2.3 Favorable reimbursement policies for daratumumab in the South Korean healthcare system

4.3 Market Restraints

4.3.1 Competition from other treatment options for multiple myeloma

4.3.2 Regulatory hurdles and approval processes for daratumumab

4.3.3 Potential side effects or safety concerns associated with daratumumab

5 South Korea Daratumumab Market Trends

6 South Korea Daratumumab Market, By Types

6.1 South Korea Daratumumab Market, By Product Type

6.1.1 Overview and Analysis

6.1.2 South Korea Daratumumab Market Revenues & Volume, By Product Type, 2021 - 2031F

6.1.3 South Korea Daratumumab Market Revenues & Volume, By Injectable Daratumumab, 2021 - 2031F

6.1.4 South Korea Daratumumab Market Revenues & Volume, By Daratumumab Biosimilar, 2021 - 2031F

6.1.5 South Korea Daratumumab Market Revenues & Volume, By Combination Therapy, 2021 - 2031F

6.1.6 South Korea Daratumumab Market Revenues & Volume, By Oral Daratumumab, 2021 - 2031F

6.2 South Korea Daratumumab Market, By Technology Type

6.2.1 Overview and Analysis

6.2.2 South Korea Daratumumab Market Revenues & Volume, By Monoclonal Antibody, 2021 - 2031F

6.2.3 South Korea Daratumumab Market Revenues & Volume, By Biosimilar Technology, 2021 - 2031F

6.2.4 South Korea Daratumumab Market Revenues & Volume, By Immunotherapy, 2021 - 2031F

6.2.5 South Korea Daratumumab Market Revenues & Volume, By Oral Drug Delivery, 2021 - 2031F

6.3 South Korea Daratumumab Market, By End User

6.3.1 Overview and Analysis

6.3.2 South Korea Daratumumab Market Revenues & Volume, By Oncologists, 2021 - 2031F

6.3.3 South Korea Daratumumab Market Revenues & Volume, By Healthcare Providers, 2021 - 2031F

6.3.4 South Korea Daratumumab Market Revenues & Volume, By Cancer Patients, 2021 - 2031F

6.3.5 South Korea Daratumumab Market Revenues & Volume, By Cancer Treatment Centers, 2021 - 2031F

6.4 South Korea Daratumumab Market, By Application

6.4.1 Overview and Analysis

6.4.2 South Korea Daratumumab Market Revenues & Volume, By Multiple Myeloma Treatment, 2021 - 2031F

6.4.3 South Korea Daratumumab Market Revenues & Volume, By Cancer Therapy, 2021 - 2031F

6.4.4 South Korea Daratumumab Market Revenues & Volume, By Co-Therapy with Chemotherapy, 2021 - 2031F

6.4.5 South Korea Daratumumab Market Revenues & Volume, By Advanced Myeloma Care, 2021 - 2031F

7 South Korea Daratumumab Market Import-Export Trade Statistics

7.1 South Korea Daratumumab Market Export to Major Countries

7.2 South Korea Daratumumab Market Imports from Major Countries

8 South Korea Daratumumab Market Key Performance Indicators

8.1 Patient adherence rate to daratumumab treatment

8.2 Number of healthcare facilities offering daratumumab treatment

8.3 Rate of new clinical trials and studies on daratumumab in South Korea

9 South Korea Daratumumab Market - Opportunity Assessment

9.1 South Korea Daratumumab Market Opportunity Assessment, By Product Type, 2021 & 2031F

9.2 South Korea Daratumumab Market Opportunity Assessment, By Technology Type, 2021 & 2031F

9.3 South Korea Daratumumab Market Opportunity Assessment, By End User, 2021 & 2031F

9.4 South Korea Daratumumab Market Opportunity Assessment, By Application, 2021 & 2031F

10 South Korea Daratumumab Market - Competitive Landscape

10.1 South Korea Daratumumab Market Revenue Share, By Companies, 2024

10.2 South Korea Daratumumab Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here
Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Latest Reports

Industry Events and Analyst Meet

Whitepaper

Read All
Chat With 6W AI Intelligence